| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H GBP CAP | RVI JAPÓN | 31,23% | 92,75% | 116,64% | 376,75% |
| POLAR CAPITAL BIOTECHNOLOGY I USD DIS | RVI BIOTECNOLOGÍA | 31,23% | 88,92% | 79,95% | 319,21% |
| SCHRODER ISF EMERGING EUROPE A DIS EUR | RVI EMERGENTES EUROPA | 31,23% | · | -31,52% | 12,39% |
| SCHRODER ISF JAPANESE OPPORTUNITIES A1 ACC JPY | RVI JAPÓN VALOR | 31,23% | 58,33% | 66,52% | 107,28% |
| VANGUARD FTSE JAPAN UCITS ETF USD ACC | RVI JAPÓN | 31,23% | 66,21% | 64,68% | · |
| AB SICAV I-EMERGING MARKETS LOW VOLATILITY EQUITY PORTFOLIO S1 EUR | RENT. ABSOLUTA. VOLAT. BAJA | 31,22% | · | · | · |
| AMUNDI MSCI JAPAN ESG BROAD TRANSITION INDEX RE CAP | RVI JAPÓN | 31,22% | 62,50% | 57,59% | 130,20% |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS I EUR CAP | RVI EMERGENTES | 31,22% | 76,32% | 46,12% | · |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 31,21% | 86,93% | 76,69% | 306,26% |
| SCHRODER ISF ASIAN EQUITY YIELD A ACC USD | RVI ASIA EX-JAPÓN VALOR | 31,21% | 75,90% | 70,17% | 133,36% |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 31,20% | 36,46% | -20,60% | · |
| UBS MSCI AC ASIA EX JAPAN SELECTION UCITS ETF USD ACC | RVI ASIA EX-JAPÓN | 31,20% | 76,43% | · | · |
| AMUNDI FUNDS EMERGING WORLD EQUITY R USD (C) | RVI EMERGENTES | 31,19% | 71,13% | 50,60% | 122,32% |
| COMGEST GROWTH JAPAN EUR R ACC | RVI JAPÓN CRECIMIENTO | 31,19% | 62,80% | 12,39% | · |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 31,19% | 86,08% | 76,51% | 303,96% |
| BBVA BOLSA ASIA MF, FI | RVI ASIA EX-JAPÓN | 31,18% | 66,40% | 40,73% | 91,88% |
| DWS CONCEPT NISSAY JAPAN VALUE EQUITY JPY LC | RVI JAPÓN VALOR | 31,18% | · | · | · |
| CHALLENGE PACIFIC EQUITY L-A | RVI ASIA PACÍFICO | 31,17% | 64,32% | 39,30% | 80,88% |
| DNB FUND - DISRUPTIVE OPPORTUNITIES-N (ACC) EUR | RVI GLOBAL | 31,17% | 195,64% | · | · |
| DWS CONCEPT NISSAY JAPAN VALUE EQUITY USD LC | RVI JAPÓN VALOR | 31,17% | · | · | · |
